| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | RVI BIOTECNOLOGÍA | 23,46% | 97,02% | 72,77% | 317,08% |
| EAST CAPITAL GLOBAL FRONTIER MARKETS C EUR CAP | RVI EMERGENTES | 20,26% | 79,18% | 72,76% | · |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | RVI BIOTECNOLOGÍA | 23,17% | 96,78% | 72,75% | 316,53% |
| XTRACKERS MSCI EUROPE UTILITIES ESG SCREENED UCITS ETF 1C | RVI UTILITIES | 20,16% | 77,08% | 72,74% | 182,54% |
| PRIVILEDGE - JPMORGAN EUROZONE EQUITY (EUR) N CAP | RV EURO | 16,34% | 78,32% | 72,73% | · |
| LO FUNDS - TARGETNETZERO GLOBAL EQUITY (USD) I CAP | RVI GLOBAL | 18,89% | 75,34% | 72,72% | · |
| ROBECO BP US PREMIUM EQUITIES F EUR | RVI USA VALOR | 29,23% | 58,08% | 72,72% | 188,41% |
| FRANKLIN MUTUAL EUROPEAN W (ACC) USD | RVI EUROPA VALOR | 17,34% | 66,38% | 72,71% | · |
| MAN SYSTEMATIC EMERGING MARKETS EQUITY I EUR | RVI EMERGENTES | 30,58% | 101,55% | 72,70% | 160,71% |
| INVESCO S&P 500 QVM UCITS ETF USD DIST | RVI USA | 14,80% | 63,65% | 72,68% | · |
